<Previous Article In Issue
Volume 2, Issue 3, September 2020, Pages 129 - 131
Sorafenib Induced Complete Cytogenetic and Molecular Response in a Chronic Eosinophilic Leukemia Case with t(12;13) Translocation
Authors
Federica Ricci1, , Serena Balducci1, *, †, , Francesca Guerrini1, Susanna Grassi1, Elena Ciabatti1, Claudia Baratè2, Maria Immacolata Ferreri3, Cecilia Giuliani3, Angelo Valetto3, Mario Petrini1, Sara Galimberti1
1Department of Clinical and Experimental Medicine, UO Hematology, University of Pisa, Pisa, Italy
2UO Hematology, Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy
3UO Cytogenetics, Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy
†
First co-author.
*Corresponding author. Email: s.balducci811@gmail.com
Corresponding Author
Serena Balducci
Received 5 June 2020, Accepted 5 July 2020, Available Online 27 July 2020.
- DOI
- 10.2991/chi.k.200714.001How to use a DOI?
- Keywords
- Chronic eosinophilic leukemia; t(12;13); ETV6/FLT3; Sorafenib
- Copyright
- © 2020 International Academy for Clinical Hematology. Publishing services by Atlantis Press International B.V.
- Open Access
- This is an open access article distributed under the CC BY-NC 4.0 license (http://creativecommons.org/licenses/by-nc/4.0/).
Download article (PDF)
View full text (HTML)
<Previous Article In Issue
Cite this article
TY - JOUR AU - Federica Ricci AU - Serena Balducci AU - Francesca Guerrini AU - Susanna Grassi AU - Elena Ciabatti AU - Claudia Baratè AU - Maria Immacolata Ferreri AU - Cecilia Giuliani AU - Angelo Valetto AU - Mario Petrini AU - Sara Galimberti PY - 2020 DA - 2020/07/27 TI - Sorafenib Induced Complete Cytogenetic and Molecular Response in a Chronic Eosinophilic Leukemia Case with t(12;13) Translocation JO - Clinical Hematology International SP - 129 EP - 131 VL - 2 IS - 3 SN - 2590-0048 UR - https://doi.org/10.2991/chi.k.200714.001 DO - 10.2991/chi.k.200714.001 ID - Ricci2020 ER -